USE OF FAECAL CALPROTECTIN AS A PROGNOSTIC MARKER OF RESPONSE TO TREATMENT WITH FILGOTINIB: POST HOC ANALYSIS FROM THE SELECTION STUDY

Edouard Louis  1     Brian G. Feagan  2     Tadakazu Hisamatsu  3     Virginia Taliadouros  4     Rob Jongen  5     Carole Van der Donckt  5     Laurent Peyrin-Biroulet  6    
1 CHU Liège University Hospital, Liège, Belgium
2 Alimentiv, London, Canada
3 Kyorin University School of Medicine, Tokyo, Japan
4 Galapagos NV, Leiden, Netherlands
5 Galapagos NV, Mechelen, Belgium
6 University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France

Session
IBD (Posters)

Conference
UEG Week Vienna 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing